Skip to content
Home/Companies/Biotech/Clean Biologics
Clean Biologics

Clean Biologics

Biotech·France·Exited 2024·Held 6yr
Entry
2018
Hold
6yr
Exit
2024

Who owns Clean Biologics?

Clean Biologics is a French Biotech company, formerly owned by ARCHIMED, exited in 2024 (exit via Continuation Vehicle). No current private equity owner is on file.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
ARCHIMED
Investor
ARCHIMED
MED II · 2017 · Buyout

Key facts

HQFrance
SectorBiotech
Websitewww.clean-biologics.com
Exit Type
Continuation Vehicle
Buyer
MED Bio
Exit Year
2024

More from MED II

Other portfolio companies in the same fund.

Ceva Sante Animale
Ceva Sante Animale
Active
PharmaFrance· 2025
DIESSE
Diesse
4.6xExited 2025
MedTechItaly· 2019
to Fremman Capital
Provepharm
Provepharm
Active
BiotechFrance· 2018
Soest Medical Group
Soest Medical Group
Active
MedTechThe Netherlands· 2018

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Clean Biologics?

Clean Biologics was formerly owned by ARCHIMED, exited in 2024. No current private equity owner is on file.

Who did Clean Biologics sell to?

ARCHIMED sold Clean Biologics to MED Bio in 2024 (Continuation Vehicle).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue